EP1135680A4 - A high-throughput system for evaluating the clinical utility of molecular targets in tissue samples - Google Patents

A high-throughput system for evaluating the clinical utility of molecular targets in tissue samples

Info

Publication number
EP1135680A4
EP1135680A4 EP00965348A EP00965348A EP1135680A4 EP 1135680 A4 EP1135680 A4 EP 1135680A4 EP 00965348 A EP00965348 A EP 00965348A EP 00965348 A EP00965348 A EP 00965348A EP 1135680 A4 EP1135680 A4 EP 1135680A4
Authority
EP
European Patent Office
Prior art keywords
evaluating
tissue samples
molecular targets
clinical utility
throughput system
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP00965348A
Other languages
German (de)
French (fr)
Other versions
EP1135680A1 (en
Inventor
Medical Systems Inc Ventana
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ventana Medical Systems Inc
Original Assignee
Ventana Medical Systems Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ventana Medical Systems Inc filed Critical Ventana Medical Systems Inc
Publication of EP1135680A1 publication Critical patent/EP1135680A1/en
Publication of EP1135680A4 publication Critical patent/EP1135680A4/en
Withdrawn legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5082—Supracellular entities, e.g. tissue, organisms
    • G01N33/5088—Supracellular entities, e.g. tissue, organisms of vertebrates
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/566—Immunoassay; Biospecific binding assay; Materials therefor using specific carrier or receptor proteins as ligand binding reagents where possible specific carrier or receptor proteins are classified with their target compounds
    • G01N33/567—Immunoassay; Biospecific binding assay; Materials therefor using specific carrier or receptor proteins as ligand binding reagents where possible specific carrier or receptor proteins are classified with their target compounds utilising isolate of tissue or organ as binding agent
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
EP00965348A 1999-09-24 2000-09-22 A high-throughput system for evaluating the clinical utility of molecular targets in tissue samples Withdrawn EP1135680A4 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US15566599P 1999-09-24 1999-09-24
US155665P 1999-09-24
PCT/US2000/026113 WO2001022086A1 (en) 1999-09-24 2000-09-22 A high-throughput system for evaluating the clinical utility of molecular targets in tissue samples

Publications (2)

Publication Number Publication Date
EP1135680A1 EP1135680A1 (en) 2001-09-26
EP1135680A4 true EP1135680A4 (en) 2004-12-15

Family

ID=22556298

Family Applications (1)

Application Number Title Priority Date Filing Date
EP00965348A Withdrawn EP1135680A4 (en) 1999-09-24 2000-09-22 A high-throughput system for evaluating the clinical utility of molecular targets in tissue samples

Country Status (3)

Country Link
EP (1) EP1135680A4 (en)
JP (1) JP2003510571A (en)
WO (1) WO2001022086A1 (en)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7219016B2 (en) 2001-04-20 2007-05-15 Yale University Systems and methods for automated analysis of cells and tissues
US20040215087A1 (en) * 2001-06-05 2004-10-28 Genero Mario Hugo Compositions and methods for the detection of biomarkers associated with cardiovascular disease
HU2464U (en) 2002-06-25 2003-03-28 Szekeres Gyoergy Dr Hand instrument set for constructing tissue array
US8012693B2 (en) 2003-12-16 2011-09-06 3M Innovative Properties Company Analysis of chemically crosslinked cellular samples
DE102004028303A1 (en) 2004-06-11 2005-12-29 Roche Diagnostics Gmbh Method and device for detecting analytes
ES2234440B1 (en) * 2004-11-18 2006-02-16 Grifols, S.A. APPLIANCE FOR AUTOMATED CLINICAL ANALYSIS OF SAMPLES.
US7405056B2 (en) 2005-03-02 2008-07-29 Edward Lam Tissue punch and tissue sample labeling methods and devices for microarray preparation, archiving and documentation
US8367351B2 (en) 2006-05-05 2013-02-05 Historx, Inc. Methods for determining signal transduction activity in tumors
DE102007017807A1 (en) 2006-05-19 2008-02-14 Merz, Hartmut, Prof. Dr. med. Apparatus and method for producing samples placed on slides
WO2008008500A2 (en) 2006-07-13 2008-01-17 Yale University Methods for making cancer prognoses based on the subcellular localization of biomarkers
GB0908142D0 (en) * 2009-05-12 2009-06-24 Cancer Res Inst Royal Sample cutter and production of tissue arrays
JP2011013050A (en) * 2009-06-30 2011-01-20 Pathology Institute Method for preparing biosample specimen
US10746752B2 (en) 2009-11-13 2020-08-18 Ventana Medical Systems, Inc. Opposables and automated specimen processing systems with opposables
US9689780B2 (en) * 2012-07-24 2017-06-27 Cryoxtract Instruments, Llc Apparatus and methods for aliquotting frozen samples
US11274998B2 (en) 2012-12-26 2022-03-15 Ventana Medical Systems, Inc. Specimen processing systems and methods for holding slides
US9989448B2 (en) 2012-12-26 2018-06-05 Ventana Medical Systems, Inc. Specimen processing systems and methods for holding slides
AU2013369471B2 (en) * 2012-12-26 2016-05-26 Ventana Medical Systems, Inc. Specimen processing systems and method for uniformly heating slides
US9488639B2 (en) * 2013-02-25 2016-11-08 Flagship Biosciences, Inc. Cell-based tissue analysis
AU2014363678B2 (en) 2013-12-13 2016-12-08 Ventana Medical Systems, Inc. Staining reagents and other liquids for histological processing of biological specimens and associated technology
JP6378770B2 (en) * 2013-12-13 2018-08-22 ベンタナ メディカル システムズ， インコーポレイテッド Thermal management and related techniques in the context of automated histological processing of biological samples

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999044062A1 (en) * 1998-02-25 1999-09-02 The United States Of America As Represented By The Secretary Department Of Health And Human Services Cellular arrays for rapid molecular profiling
WO1999044030A1 (en) * 1998-02-27 1999-09-02 Ventana Medical Systems, Inc. Automated molecular pathology apparatus having independent slide heaters

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6103518A (en) * 1999-03-05 2000-08-15 Beecher Instruments Instrument for constructing tissue arrays

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999044062A1 (en) * 1998-02-25 1999-09-02 The United States Of America As Represented By The Secretary Department Of Health And Human Services Cellular arrays for rapid molecular profiling
WO1999044030A1 (en) * 1998-02-27 1999-09-02 Ventana Medical Systems, Inc. Automated molecular pathology apparatus having independent slide heaters

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See also references of WO0122086A1 *

Also Published As

Publication number Publication date
EP1135680A1 (en) 2001-09-26
WO2001022086A1 (en) 2001-03-29
JP2003510571A (en) 2003-03-18

Similar Documents

Publication Publication Date Title
EP1135680A4 (en) A high-throughput system for evaluating the clinical utility of molecular targets in tissue samples
GB2351556B (en) Improved assay analysis
AU6093400A (en) Automated detection of objects in a biological sample
AU3363000A (en) Devices and methods for frequent measurement of an analyte present in a biological system
AU7747600A (en) Microfabricated liquid sample loading system
AU5459000A (en) Highly sensitive biological agent probe
AU2170901A (en) Branched compound for use in nucleic acid detection and analysis reactions
AU1402201A (en) Assay for measuring enzyme activity in vivo
AU2002237662A1 (en) Analysis of soluble factor biological markers
GB2351555B (en) Improved assay analysis
AU7987800A (en) Anti-aging nucleic acid and protein targets
GB2395266B (en) Improved assay analysis
AU6418200A (en) Analysis of biological fluids
AU6042700A (en) Probe for analysis of nucleic acids
AU6925800A (en) Autogrid analysis
AUPQ209999A0 (en) Automated sample analysis system
AU3968799A (en) Algorithmic testing in laboratory medicine
GB9922952D0 (en) Urine collection vessels
GB9920344D0 (en) Biological assay
AUPP918399A0 (en) Measurement probe
AUPP845099A0 (en) Biological assay
GB9914902D0 (en) Improved assay analysis
GB9915032D0 (en) Improved assay analysis
GB9907641D0 (en) Protein analysis
GB9914874D0 (en) Protein analysis

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20010611

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

RAP1 Party data changed (applicant data changed or rights of an application transferred)

Owner name: VENTANA MEDICAL SYSTEMS, INC.

RIN1 Information on inventor provided before grant (corrected)

Inventor name: VENTANA MEDICAL SYSTEMS, INC.

A4 Supplementary search report drawn up and despatched

Effective date: 20041104

17Q First examination report despatched

Effective date: 20050413

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20051025